文献库搜索 | GeneLibs

Ashford(AJ),Lapadat(A),Demir(E) bioRxiv 2026-08-12

...KRAS (0.944). Determining which programs transfer therefore becomes the central task. We address it with a ground-truth-...

Noda(T),Shirahama(H),Tani(Y),Tomida(A) Biochem Biophys Res Commun 2026-09-24

...KRAS, or BRAF drove resistance to cystine deprivation-induced ferroptosis in cancer cells harboring each driver mutation...

Daruish(M),Gadeyne(L),Bonenfant(C),Taibjee... Virchows Arch 2026-08-03

...KRAS mutations in 3 of the 4 cases harboring a sebaceous component and also in the specimen with combined IFK and tubula...

Natti(HS),Gumdal(V),Koppaka(D),Nuguri(S),P... J Assoc Physicians India 2026-07-00

...KRAS) mutations were detected in 20.7% of patients, whereas microsatellite instability-high (MSI-high) status was identi...

Witz(A),Conroy(T),Lambert(A),Salleron(J),D... J Clin Oncol 2026-08-03

...KRAS-mutated patients, mFFX significantly improved DFS compared with GEM (sHR, 0.60 [95% CI, 0.45 to 0.79]; P < .001), w...

Sun(Y),Song(M),Ding(W),Liu(Q),Lu(W),Luo(B)... Cancer Lett 2026-08-03

...KRAS-driven cancer via a tetracycline-inducible cell-based drug screening. dPTBD exhibited significant antitumor efficac...

Kumar(R),Thian(J),Toh(JDW),Farzana(N),Sun(... ACS Med Chem Lett 2026-03-12

...KRAS mutant Non-Small Cell Lung Cancer (NSCLC) cells, which may eventually overcome drug resistance associated with the ...

Meng(L),Liang(SH) ACS Med Chem Lett 2026-03-12

...KRAS oncogene, which is the most frequently mutated in human cancers. These compounds, along with their pharmaceutical c...

Huang(X),Huang(J),Hong(Q),Ou(X),Li(R),Zong... ACS Med Chem Lett 2026-03-12

...KRAS reactivation. SOS1, a key guanine nucleotide exchange factor involved in KRAS activation and implicated in various ...

Hill(AL),Cullinan(DR),Ahmed(O),Wesson(R),S... J Am Coll Surg 2026-08-01

...KRAS mutation was statistically significantly associated with recurrence (p = 0.01). Transplant was performed a median o...